Olanzapine-Induced Diabetic Ketoacidosis and Neuroleptic Malignant Syndrome with Rhabdomyolysis: A Case Report

Atypical antipsychotics have replaced conventional antipsychotics in the treatment of schizophrenia because they have less of a propensity to cause undesirable neurologic adverse events including extrapyramidal symptoms, tardive dyskinesia, and neuroleptic malignant syndrome (NMS). However, atypical...

Descripción completa

Detalles Bibliográficos

Autores principales:	Young Kyoung Sa, Hyeon Yang, Hee Kyoung Jung, Jang Won Son, Seong Su Lee, Seong Rae Kim, Bong Yeon Cha, Ho Young Son, Chi-Un Pae, Soon Jib Yoo
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Korean Endocrine Society 2013-03-01
Colección:	Endocrinology and Metabolism
Materias:	Diabetic ketoacidosis Neuroleptic malignant syndrome Olanzapine
Acceso en línea:	http://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-28-70.pdf
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!